Patents by Inventor Angela Scaburri

Angela Scaburri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CDK inhibitor for the treatment of mesothelioma
    Patent number: 8912194
    Abstract: The invention provides a low molecular weight ATP-competitive CDK inhibitor for use in the treatment of mesothelioma. The compound can be administered together with one or more cytotoxic or cytostatic agents.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: December 16, 2014
    Assignee: Nerviano Medical Sciences S.R.L.
    Inventors: Marina Ciomei, Angela Scaburri
  • Use of kinase inhibitor for the treatment of thymoma
    Patent number: 8580793
    Abstract: The invention provides a low molecular weight ATP-competitive CDK inhibitor and TRKA inhibitor of formula (I) for use in the treatment of thymoma and thymic carcinoma. The compound can be administered together with one or more cytotoxic or cytostatic agents.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: November 12, 2013
    Assignee: Nerviano Medical Services S.r.l.
    Inventors: Angela Scaburri, Maria Adele Pacciarini, Marina Ciomei, Bernard Laffranchi, Silvia Comis
  • USE OF KINASE INHIBITOR FOR THE TREATMENT OF THYMOMA
    Publication number: 20120077819
    Abstract: The invention provides a low molecular weight ATP-competitive CDK inhibitor and TRKA inhibitor of formula (I) for use in the treatment of thymoma and thymic carcinoma. The compound can be administered together with one or more cytotoxic or cytostatic agents.
    Type: Application
    Filed: March 15, 2010
    Publication date: March 29, 2012
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Angela Scaburri, Maria Adele Pacciarini, Marina Ciomei, Bernard Laffranchi, Silvia Comis
  • CDK INHIBITOR FOR THE TREATMENT OF MESOTHELIOMA
    Publication number: 20110224222
    Abstract: The invention provides a low molecular weight ATP-competitive CDK inhibitor for use in the treatment of mesothelioma. The compound can be administered together with one or more cytotoxic or cytostatic agents.
    Type: Application
    Filed: November 23, 2009
    Publication date: September 15, 2011
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Marina Ciomei, Angela Scaburri